Cetkovský P - Search Results

1

CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia.

Hájková H, Fritz MH, Haškovec C, Schwarz J, Šálek C, Marková J, Krejčík Z, Dostálová Merkerová M, Kostečka A, Vostrý M, Fuchs O, Michalová K, Cetkovský P, Beneš V. Hájková H, et al. Among authors: cetkovsky p. J Hematol Oncol. 2014 Sep 30;7:66. doi: 10.1186/s13045-014-0066-4. J Hematol Oncol. 2014. PMID: 25266220 Free PMC article.

2

Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.

Hájková H, Marková J, Haškovec C, Sárová I, Fuchs O, Kostečka A, Cetkovský P, Michalová K, Schwarz J. Hájková H, et al. Among authors: cetkovsky p. Leuk Res. 2012 Sep;36(9):1128-33. doi: 10.1016/j.leukres.2012.05.012. Epub 2012 Jun 28. Leuk Res. 2012. PMID: 22749068

3

Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia.

Marková J, Michková P, Burčková K, Březinová J, Michalová K, Dohnalová A, Maaloufová JS, Soukup P, Vítek A, Cetkovský P, Schwarz J. Marková J, et al. Among authors: cetkovsky p. Eur J Haematol. 2012 Feb;88(2):128-35. doi: 10.1111/j.1600-0609.2011.01716.x. Epub 2011 Nov 17. Eur J Haematol. 2012. PMID: 21967546

4

DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations.

Šestáková Š, Krejčík Z, Folta A, Cerovská E, Šálek C, Merkerová MD, Pecherková P, Ráčil Z, Mayer J, Cetkovský P, Remešová H. Šestáková Š, et al. Among authors: cetkovsky p. Cancer Biomark. 2019;25(1):43-51. doi: 10.3233/CBM-182176. Cancer Biomark. 2019. PMID: 30988238

5

A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel.

Šestáková Š, Cerovská E, Šálek C, Kundrát D, Ježíšková I, Folta A, Mayer J, Ráčil Z, Cetkovský P, Remešová H. Šestáková Š, et al. Among authors: cetkovsky p. Clin Epigenetics. 2022 Feb 11;14(1):22. doi: 10.1186/s13148-022-01242-6. Clin Epigenetics. 2022. PMID: 35148810 Free PMC article.

6

Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome.

Marková J, Marková J, Trnková Z, Michková P, Maaloufová J, Starý J, Cetkovský P, Schwarz J. Marková J, et al. Among authors: cetkovsky p. Leuk Lymphoma. 2009 Sep;50(9):1448-60. doi: 10.1080/10428190903085951. Leuk Lymphoma. 2009. PMID: 19603346

7

A single administration of gemtuzumab ozogamicin for molecular relapse of acute promyelocytic leukemia.

Schwarz J, Marková J, Peková S, Trnková Z, Sponerová D, Cetkovský P. Schwarz J, et al. Among authors: cetkovsky p. Hematol J. 2004;5(3):279-80. doi: 10.1038/sj.thj.6200367. Hematol J. 2004. PMID: 15167917 No abstract available.

8

Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis.

Válková V, Polák J, Marková M, Vítek A, Hájková H, Sálek C, Procházka B, Cetkovský P, Trněný M. Válková V, et al. Among authors: cetkovsky p. Clin Transplant. 2013 Jan-Feb;27(1):E21-9. doi: 10.1111/ctr.12046. Epub 2012 Dec 12. Clin Transplant. 2013. PMID: 23231003

9

Touch-down reverse transcriptase-PCR detection of IgV(H) rearrangement and Sybr-Green-based real-time RT-PCR quantitation of minimal residual disease in patients with chronic lymphocytic leukemia.

Peková S, Marková J, Pajer P, Dvorák M, Cetkovský P, Schwarz J. Peková S, et al. Among authors: cetkovsky p. Mol Diagn. 2005;9(1):23-34. doi: 10.2165/00066982-200509010-00004. Mol Diagn. 2005. PMID: 16035732

10

Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission.

Vydra J, Šálek C, Schwarz J, Žák P, Novák J, Petečuková V, Pecherková P, Mayer J, Cetkovský P, Ráčil Z. Vydra J, et al. Among authors: cetkovsky p. Clin Lymphoma Myeloma Leuk. 2018 Feb;18(2):106-113. doi: 10.1016/j.clml.2017.11.011. Epub 2017 Dec 7. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29289481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters